These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 30100613)

  • 1. Development of an evidence-based algorithm that optimizes sensitivity and specificity in ES-based diagnostics of a clinically heterogeneous patient population.
    Bauer P; Kandaswamy KK; Weiss MER; Paknia O; Werber M; Bertoli-Avella AM; Yüksel Z; Bochinska M; Oprea GE; Kishore S; Weckesser V; Karges E; Rolfs A
    Genet Med; 2019 Jan; 21(1):53-61. PubMed ID: 30100613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance comparison: exome sequencing as a single test replacing Sanger sequencing.
    Fridman H; Bormans C; Einhorn M; Au D; Bormans A; Porat Y; Sanchez LF; Manning B; Levy-Lahad E; Behar DM
    Mol Genet Genomics; 2021 May; 296(3):653-663. PubMed ID: 33694043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A machine learning model to determine the accuracy of variant calls in capture-based next generation sequencing.
    van den Akker J; Mishne G; Zimmer AD; Zhou AY
    BMC Genomics; 2018 Apr; 19(1):263. PubMed ID: 29665779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotype-driven variant filtration strategy in exome sequencing toward a high diagnostic yield and identification of 85 novel variants in 400 patients with rare Mendelian disorders.
    Marinakis NM; Svingou M; Veltra D; Kekou K; Sofocleous C; Tilemis FN; Kosma K; Tsoutsou E; Fryssira H; Traeger-Synodinos J
    Am J Med Genet A; 2021 Aug; 185(8):2561-2571. PubMed ID: 34008892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sanger Confirmation Is Required to Achieve Optimal Sensitivity and Specificity in Next-Generation Sequencing Panel Testing.
    Mu W; Lu HM; Chen J; Li S; Elliott AM
    J Mol Diagn; 2016 Nov; 18(6):923-932. PubMed ID: 27720647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic yield and clinical utility of whole exome sequencing using an automated variant prioritization system, EVIDENCE.
    Seo GH; Kim T; Choi IH; Park JY; Lee J; Kim S; Won DG; Oh A; Lee Y; Choi J; Lee H; Kang HG; Cho HY; Cho MH; Kim YJ; Yoon YH; Eun BL; Desnick RJ; Keum C; Lee BH
    Clin Genet; 2020 Dec; 98(6):562-570. PubMed ID: 32901917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A post-hoc comparison of the utility of sanger sequencing and exome sequencing for the diagnosis of heterogeneous diseases.
    Neveling K; Feenstra I; Gilissen C; Hoefsloot LH; Kamsteeg EJ; Mensenkamp AR; Rodenburg RJ; Yntema HG; Spruijt L; Vermeer S; Rinne T; van Gassen KL; Bodmer D; Lugtenberg D; de Reuver R; Buijsman W; Derks RC; Wieskamp N; van den Heuvel B; Ligtenberg MJ; Kremer H; Koolen DA; van de Warrenburg BP; Cremers FP; Marcelis CL; Smeitink JA; Wortmann SB; van Zelst-Stams WA; Veltman JA; Brunner HG; Scheffer H; Nelen MR
    Hum Mutat; 2013 Dec; 34(12):1721-6. PubMed ID: 24123792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the necessity of confirmatory testing for exome-sequencing results in a clinical molecular diagnostic laboratory.
    Strom SP; Lee H; Das K; Vilain E; Nelson SF; Grody WW; Deignan JL
    Genet Med; 2014 Jul; 16(7):510-5. PubMed ID: 24406459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic Evaluation of Sanger Validation of Next-Generation Sequencing Variants.
    Beck TF; Mullikin JC; ; Biesecker LG
    Clin Chem; 2016 Apr; 62(4):647-54. PubMed ID: 26847218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relevance of next generation sequencing (NGS) data re-analysis in the diagnosis of monogenic diseases leading to organ failure.
    Saglia C; Bracciamà V; Trotta L; Mioli F; Faini AC; Brach Del Prever GM; Kalantari S; Luca M; Romeo CM; Scolari C; Peruzzi L; Calvo PL; Mussa A; Fenoglio R; Roccatello D; Alberti C; Carli D; Amoroso A; Deaglio S; Vaisitti T
    BMC Med Genomics; 2023 Nov; 16(1):303. PubMed ID: 38012624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exome and genome sequencing for inborn errors of immunity.
    Meyts I; Bosch B; Bolze A; Boisson B; Itan Y; Belkadi A; Pedergnana V; Moens L; Picard C; Cobat A; Bossuyt X; Abel L; Casanova JL
    J Allergy Clin Immunol; 2016 Oct; 138(4):957-969. PubMed ID: 27720020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exome sequencing covers >98% of mutations identified on targeted next generation sequencing panels.
    LaDuca H; Farwell KD; Vuong H; Lu HM; Mu W; Shahmirzadi L; Tang S; Chen J; Bhide S; Chao EC
    PLoS One; 2017; 12(2):e0170843. PubMed ID: 28152038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Next-generation sequencing using a pre-designed gene panel for the molecular diagnosis of congenital disorders in pediatric patients.
    Lim EC; Brett M; Lai AH; Lee SP; Tan ES; Jamuar SS; Ng IS; Tan EC
    Hum Genomics; 2015 Dec; 9():33. PubMed ID: 26666243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation of Exome Sequencing to Identify Rare Genetic Diseases.
    Udupa P; Ghosh DK
    Methods Mol Biol; 2024; 2719():79-98. PubMed ID: 37803113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A highly sensitive and specific workflow for detecting rare copy-number variants from exome sequencing data.
    Rajagopalan R; Murrell JR; Luo M; Conlin LK
    Genome Med; 2020 Jan; 12(1):14. PubMed ID: 32000839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VarBin, a novel method for classifying true and false positive variants in NGS data.
    Durtschi J; Margraf RL; Coonrod EM; Mallempati KC; Voelkerding KV
    BMC Bioinformatics; 2013; 14 Suppl 13(Suppl 13):S2. PubMed ID: 24266885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Confirming Variants in Next-Generation Sequencing Panel Testing by Sanger Sequencing.
    Baudhuin LM; Lagerstedt SA; Klee EW; Fadra N; Oglesbee D; Ferber MJ
    J Mol Diagn; 2015 Jul; 17(4):456-61. PubMed ID: 25960255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Orthogonal NGS for High Throughput Clinical Diagnostics.
    Chennagiri N; White EJ; Frieden A; Lopez E; Lieber DS; Nikiforov A; Ross T; Batorsky R; Hansen S; Lip V; Luquette LJ; Mauceli E; Margulies D; Milos PM; Napolitano N; Nizzari MM; Yu T; Thompson JF
    Sci Rep; 2016 Apr; 6():24650. PubMed ID: 27090146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted 46-gene and clinical exome sequencing for mutations causing cardiomyopathies.
    Waldmüller S; Schroeder C; Sturm M; Scheffold T; Imbrich K; Junker S; Frische C; Hofbeck M; Bauer P; Bonin M; Gawaz M; Gramlich M
    Mol Cell Probes; 2015 Oct; 29(5):308-14. PubMed ID: 25979592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome Sequencing for Diagnosing Rare Diseases.
    Wojcik MH; Lemire G; Berger E; Zaki MS; Wissmann M; Win W; White SM; Weisburd B; Wieczorek D; Waddell LB; Verboon JM; VanNoy GE; Töpf A; Tan TY; Syrbe S; Strehlow V; Straub V; Stenton SL; Snow H; Singer-Berk M; Silver J; Shril S; Seaby EG; Schneider R; Sankaran VG; Sanchis-Juan A; Russell KA; Reinson K; Ravenscroft G; Radtke M; Popp D; Polster T; Platzer K; Pierce EA; Place EM; Pajusalu S; Pais L; Õunap K; Osei-Owusu I; Opperman H; Okur V; Oja KT; O'Leary M; O'Heir E; Morel CF; Merkenschlager A; Marchant RG; Mangilog BE; Madden JA; MacArthur D; Lovgren A; Lerner-Ellis JP; Lin J; Laing N; Hildebrandt F; Hentschel J; Groopman E; Goodrich J; Gleeson JG; Ghaoui R; Genetti CA; Gburek-Augustat J; Gazda HT; Ganesh VS; Ganapathi M; Gallacher L; Fu JM; Evangelista E; England E; Donkervoort S; DiTroia S; Cooper ST; Chung WK; Christodoulou J; Chao KR; Cato LD; Bujakowska KM; Bryen SJ; Brand H; Bönnemann CG; Beggs AH; Baxter SM; Bartolomaeus T; Agrawal PB; Talkowski M; Austin-Tse C; Abou Jamra R; Rehm HL; O'Donnell-Luria A
    N Engl J Med; 2024 Jun; 390(21):1985-1997. PubMed ID: 38838312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.